[The testing of the new spasmolytic benzilic acid-(N,N-dimethyl-2-hydroxymethylpiperidinium)estermethylsulfate in the clinic and practice].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000818:Animals; D001561:Benzilates / Q000494:pharmacology* / Q000627:therapeutic use*; D001660:Biliary Tract Diseases / Q000188:drug therapy; D001775:Blood Circulation / Q000187:drug effects; D002319:Cardiovascular System / Q000187:drug effects; D002415:Cats; D002490:Central Nervous System / Q000187:drug effects; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004285:Dogs; D005260:Female; D005767:Gastrointestinal Diseases / Q000188:drug therapy; D005831:Genital Diseases, Female / Q000188:drug therapy; D006168:Guinea Pigs; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D051379:Mice; D008875:Middle Aged; D009119:Muscle Contraction / Q000187:drug effects; D009132:Muscles / Q000494:pharmacology* / Q000627:therapeutic use*; D009135:Muscular Diseases / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy; D010880:Piperidines / Q000494:pharmacology* / Q000627:therapeutic use*; D011680:Pupil / Q000187:drug effects; D011817:Rabbits; D051381:Rats; D012119:Respiration / Q000187:drug effects; D012140:Respiratory Tract Diseases / Q000188:drug therapy; D012472:Salivation / Q000187:drug effects; D014570:Urologic Diseases / Q000188:drug therapy
D001561:Benzilates; D010880:Piperidines
Die Prüfung des neuen Spasmolyticums Benzilsäure-(N,N-dimethyl-2-hydroxymethyl-piperidinium)-ester-methylsulfat in Klinik und Praxis.